Abstract
In breast cancer, interruption of estrogen receptor (ER)-α function is an effective therapeutic strategy. Despite the clinical benefit of interruption of ER-α function, the precise biological action of ER-α in breast tumors is not completely understood. Results of a recent study show that ER-α promotes growth of breast cancer cells by targeting expression of signaling components of the insulin-like growth factor system. Intriguingly, the authors of this study raise the possibility that unliganded ER-α itself may affect gene expression and breast cancer biology, and they suggest a potential mechanism for ER-α to stimulate proliferation in breast cancer.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 62-64 |
| Number of pages | 3 |
| Journal | Breast Cancer Research |
| Volume | 4 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2002 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Breast cancer
- Estrogen receptor
- Insulin-like growth factors
Fingerprint
Dive into the research topics of 'How does the estrogen receptor work?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS